LIDOCAINE HCI AND DEXTROSE
- Product NDC
- 51662-1302
- 11-digit product format
- 516621302
- Labeler code
- 51662
- Product ID
- 51662-1302_efe725f1-35b2-3764-e053-2a95a90acb3c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LIDOCAINE HCI AND DEXTROSE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- NDA018461
- Marketing category
- NDA
- Marketing start
- 2019-04-09
- Marketing end
- 0000-00-00
- Substance
- LIDOCAINE HYDROCHLORIDE
- Active strength
- 4 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1302-1 | LIDOCAINE HCI AND DEXTROSE | 500 mL in 1 BAG | INJECTION, SOLUTION | 500 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1302 | LIDOCAINE HCI AND DEXTROSE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 3 | Legacy NDC, 1 package rows | 20221220_861ba61a-5835-3b9a-e053-2a91aa0aee5e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1302-1 | 51662130201 | 500 mL in 1 BAG (51662-1302-1) | 500 ml | 2019-04-09 | 0000-00-00 | No | No | Current |